AI in Neuroscience: Partnering with DANNCE.AI to Increase Drug Efficacy & Improve the Lives of People with Movement Disorders

AI in Neuroscience: Partnering with DANNCE.AI to Increase Drug Efficacy & Improve the Lives of People with Movement Disorders

DANNCE.AI is bringing to market a novel phenotyping platform to digitize the clinical assessments used by clinicians and drug developers to quantify movement. We led their $2.6M pre-seed round along with co-investors Glasswing Ventures, The Leo Lion Company, Duke Capital Partners, and Merck Digital Sciences Studio.

Read More

LDV Community Helping Entrepreneurs Succeed For 11 Years

LDV Community Helping Entrepreneurs Succeed For 11 Years

Thrilled to present a selection of photos capturing moments from our recent invite-only "Happy Hour" event, held in New York City. This event brought together outstanding technology innovators, serial entrepreneurs, deep tech researchers, and investors from within the vibrant New York tech ecosystem.

Read More